F
Ford Motor Company
F has lower modeled downside risk, despite its lower overall score.
HZO
MarineMax, Inc.
HZO has a slight edge over F overall, supported by stronger fundamentals and stronger modeled upside.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
HZO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Weak |
HZO's cash flow is currently healthy, and its profitability is stable, but its revenue and balance sheet are under pressure.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
HZO PE Valuation
HZO has no meaningful PE right now: it lost money over the past year.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
HZO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect HZO's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
HZO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | — |
| Q3 2026 | -$0.41 | +$1.02 |
HZO has the edge over F in the latest year-over-year earnings comparison.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over HZO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
HZO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $520.1M | -5.8% |
| Q2 2026 | $611.3M | -7% |
| Q1 2026 | $527.4M | -16% |
| Q4 2025 | $505.2M | +7.8% |
HZO's revenue has slid since its 2025 peak: $520M last quarter, down 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 6.1% | +12 points |
| Q1 2026 | 2% | -1.6 points |
| Q4 2025 | 1% | -7.4 points |
| Q3 2025 | 2.5% | N/A |
| Q2 2025 | -6.3% | N/A |
| Q1 2025 | 3.6% | N/A |
| Q4 2024 | 8.3% | N/A |
HZO has the edge over F on profitability, with a higher operating margin.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
HZO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $77.2M | +13% |
| Q1 2026 | $44.5M | -26% |
| Q4 2025 | $8.3M | +$172.7M |
HZO has the edge over F in the latest year-over-year cash flow comparison.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over HZO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
HZO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.1% | +1.1M shares |
| 1 year | +7.6% | +1.6M shares |
HZO has 23M diluted shares, up 7.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q2 2025 | $15M |
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over HZO on leverage, with a lower net debt burden relative to earnings.
HZO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.8x | High |
| Q1 2026 | 22.5x | High |
| Q4 2025 | 18.3x | High |
| Q3 2025 | 11.3x | High |
| Q2 2025 | 10.4x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 5.3x | High |
HZO's net debt is about 6.8 years of its operating earnings (EBITDA), down from 10 years a year ago.
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
HZO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.2 | Overbought |
| Stochastic | 96.4 | Overbought |
HZO's weekly RSI is 78 (overbought) and its Stochastic is 96 (overbought).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
HZO PE vs Consumer Cyclical Sector
| Metric | HZO | Sector median | Relative |
|---|---|---|---|
| PE | 203x | 18x | 1,026% above |
| PE % | 100 | 47 | 53 pts above |
HZO has no meaningful PE right now: it lost money over the past year.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
HZO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.6 | 0.5% above |
| 20 week MA | $47.2 | 12% above |
| 50 week MA | $36.4 | 45% above |
| 100 week MA | $30.6 | 72% above |
| 200 week MA | $31.1 | 70% above |
HZO has the edge over F on trend strength, trading above more of its moving averages.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.
HZO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $37.8 | +127% |
| 2021 | $37.8 | $56.3 | +49% |
| 2022 | $56.3 | $31.0 | -45% |
| 2023 | $31.0 | $38.9 | +26% |
| 2024 | $38.9 | $27.8 | -29% |
| 2025 | $27.8 | $24.5 | -12% |
| 2026 YTD | $24.5 | $52.8 | +116% |
HZO has the edge over F on returns for 2026, with the stronger performance.